International Patent: COMPOUNDS AND METHODS FOR MODULATING HNRNPH2 EXPRESSION

GENEVA, July 18 -- IONIS PHARMACEUTICALS, INC. filed a patent application (US2026/010598) for “COMPOUNDS AND METHODS FOR MODULATING HNRNPH2 EXPRESSION”. With publication no. WO/2026/151867, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....